Table 5.
Drug interactions with chloroquine and hydroxychloroquine (“Red List” 2010).
No effect | CQ/HCQ reduce bioavailability of | Bioavailability of CQ/HCQ reduced by | Bioavailability of CQ/HCQ enhanced by | CQ/HCQ increase the risk of side effects of | CQ/HCQ increase plasma levels of | Diminished effect of | Increased rate of skin reactions | Increased rate of muscle weakness | |
---|---|---|---|---|---|---|---|---|---|
Acetylsalicylic acid | + | ||||||||
Aminoglycosides | + | ||||||||
Ammonium chloride | |||||||||
Ampicillin | + | ||||||||
Aurothioglucose | + | ||||||||
Kaolin/pectin | + | ||||||||
Cholestyramine | + | ||||||||
Cimetidine | + | ||||||||
Cyclosporine A | + | ||||||||
Digoxin | + | ||||||||
Corticosteroids | + | ||||||||
Imipramine | + | ||||||||
Methotrexate | + | ||||||||
Neostigmine | + | ||||||||
Penicillamine | + | ||||||||
Phenylbutazone | + | ||||||||
Physostigmine | + | ||||||||
Pyrimethamine/sulfadoxine | + | ||||||||
Quinacrine | + | ||||||||
Rabies vaccination | + | ||||||||
Ranitidine | + | ||||||||
Ritonavir | + | ||||||||
Typhus vaccination | + |